Aditx
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2569 Wyandotte St Ste 101, Mountain View...Phone Number
(650) 870-1200Website
www.aditxt.comRevenue
<$5 MillionStock Symbol
ADTXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Aditx
Aditxt, Inc.® is a social innovation platform dedicated to accelerating promising health innovations. Aditxts ecosystem of research institutions, industry partners, and shareholders collaboratively drives their mission to Make Promising Innovations Possible Together. The innovation platform is the cornerstone of Aditxts strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholders voice is heard and valued, and empowers collective progress.Explore more
Aditx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aditx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Aditx has new funding data
Click to see if Aditx had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Aditx
Check if Aditx has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aditx recently announced quarterly report
Aditx, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Aditx launches new products
Check out if Aditx is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Aditx
Compare insights from companies similar to Aditx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aditx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aditx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aditx.
Aditx financials insights
Gather financial insights about Aditx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$11M
2021
Share Placement
$4.5M
Stock Offering
$11M
Aditx Tech Stack
A closer look at the technologies used by Aditx
Most Recent Scoops
Project
Aditx has announced plans to launch a prostate cancer test and an endometriosis test through its Percent Air platform. The company sees potential synergies between Percent Air and Evofem for distributing the endometriosis test.
Mergers & Acquisitions, Product Launch, Acquisitions, Healthcare Technology, Mergers
Project
Aditx has announced several key milestones for the near future: expanding Evofem's product portfolio and distribution, validating and commercializing Percent Air by year-end, and submitting regulatory filings for AD Immune.
Product Launch, Corporate Strategy, Healthcare Technology
Project
Aditx has announced that its Percent Air tests could be priced between $200 to $400 per test, with production costs as low as $40 per test.
Product Launch, Healthcare Technology, Pricing
Project
Aditx has outlined its near-term milestones: potential revenue generation through Evofem acquisition, commercialization of Percent Air for cancer detection, and regulatory filing for AD Immune with the goal of human trials in the first half of 2026.
Product Launch, Corporate Strategy, Healthcare Technology
Project
Partnership, Business Development, Healthcare Technology
Aditx News & Media
Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million
Ignite Proteomics will separate from Aditxt and seek NYSE listing in a $150M deal, using proceeds to fund commercialization and oncology clinical evidence.Debt financing: Aditxt (NASDAQ: ADTX) sells $1.25M senior notes - Stock Titan
Aditxt issues $1.25M senior unsecured notes for $1M cash, at 10% interest, with 120–125% redemption premiums linked to future equity sales and covenants.Evofem Announces Voting Results from Special Meeting of Stockholders
-- Evofem Shareholders Did Not Approve the Merger with Aditxt -- -- Evofem Pivots to Target National Listing for Stock, Growth Capital to Catalyze Net Sales -- SAN DIEGO, Oct. 20, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCID: EVFM) ("Evofem" or the "Company"), today announced that...Aditxt Appoints New General Counsel and Officer - TipRanks.com
An update from Aditxt ( ($ADTX) ) is now available. On September 30, 2025, Aditxt, Inc. appointed Christopher J. Porcelli as General Counsel, Chief People Officer, ...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aditx
Sign Up For FreeTo access detailed company insights
Aditxt, Inc.® is a social innovation platform dedicated to accelerating promising health innovations. Aditxts ecosystem of research institutions, industry partners, and shareholders collaboratively drives their mission to Make Promising Innovations Possible Together. The innovation platform is the cornerstone of Aditxts strategy, where multiple dis... Read More
